Press Releases Events & Presentations Event Details AASLD – The Liver Meeting Nov 12 - Nov 15, 2021 Supporting Materials Poster – ABI-H3733 – Phase 1a 292.5 KB Late-Breaker Poster – ABI-4334 – Preclinical characterization 452.6 KB VBR – Despite continued treatment with NrtI, HBV pgRNA and DNA rebound following discontinuation of VBR 640.9 KB Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
AASLD – The Liver Meeting Nov 12 - Nov 15, 2021 Supporting Materials Poster – ABI-H3733 – Phase 1a 292.5 KB Late-Breaker Poster – ABI-4334 – Preclinical characterization 452.6 KB VBR – Despite continued treatment with NrtI, HBV pgRNA and DNA rebound following discontinuation of VBR 640.9 KB
VBR – Despite continued treatment with NrtI, HBV pgRNA and DNA rebound following discontinuation of VBR 640.9 KB
